Diabetes and Money

Medpage Today has been doing a series of articles about diabetes. I realize this is not the primary focus of this forum but it is instructive none the less and you will recognize some of the players involved. PR

medpagetoday.com/Endocrinol...

"A similar scenario played out in 2008, when a joint panel of two other groups -- the AACE and American College of Endocrinology -- said diabetes drugs can be used to treat pre-diabetes with "careful judgment."

Of the 17 members on that panel, 13 worked as speakers and consultants to companies that make diabetes drugs."

2 Replies

oldestnewest
  • Your last sentence reveals all without actually stating what we actually believe.

  • After reading your article and during it my blood ran cold, to think that doctors and pharmaceutical companies put monetary gain before patients' health. No wonder people want a kinder/healthier way of treating their conditions and lose faith in their doctors.

    Thank God for the investigative reporters who deserve a medal. The FDA are just as bad as the other two when they pass drugs for use despite knowing/ignoring the consequences. What of the patients who developed cancer or die. An excerpt:

    "The need for new therapies for type 2 diabetes is not so urgent that one must tolerate a significant degree of uncertainty regarding serious risk concerns," she said in her report.

    Yet the FDA approved liraglutide -- and went on to approve three more drugs in the same class, all of which carried serious risks. The four drugs, known as GLP-1 receptor agonists, all carry the agency's most stringent black box warning because the drugs cause thyroid tumors in rodents.

    another excerpt:

    That year, the association received more than $8 million from companies that market or develop diabetes drugs and related products, according to its tax form.

    Thirteen of the 19 doctors on the panel that made the recommendation, including its chairman, worked as consultants, speakers, or advisers to companies that make diabetes drugs.

    As a group, those experts got $2.1 million from the companies since 2009, according to a MedPage Today/Milwaukee Journal-Sentinel analysis of drug company data.

    That year, the association received more than $8 million from companies that market or develop diabetes drugs and related products, according to its tax form.

You may also like...